Ledger.Open graph →

SEC Form D · filed April 15, 2013

Mati Therapeutics Inc

Offering

$10.0M

Sold

$1.3M

Exemption

—

Industry

Biotechnology

Location

AUSTIN, TX

Type

—

People & firms on this filing (6)

Jon L. Stein · Chicago, ILExec · Director Nordic Venture Partners, LLC · Sioux Falls, SDExec · Director TC Group, L.L.C · Washington, Washington, D.C.Exec · Director Laurel C. Bowden · Palo Alto, CAExec · Director Yacov E. Lifshitz · Palo Alto, CAExec Robert L. Butchofsky · Austin, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗